Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross Profit | $155.9M | $192.6M | $261.8M | $291.8M | $302.6M | $303.6M | $318.1M | $339.3M | $387.7M | $434.7M | $447.8M | $455.8M | $501.1M | $512.6M | $545.4M | $605.7M | $767.8M | $1,175.8M | $1,136.2M | $1,129.2M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, West Pharmaceutical Services, Inc.'s last 12-month Gross Profit is $1,004.4M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, West Pharmaceutical Services, Inc.'s Gross Profit growth was (9.8%). The average annual Gross Profit growth rates for West Pharmaceutical Services, Inc. have been 4.8% over the past three years, 11.4% over the past five years.
Over the last year, West Pharmaceutical Services, Inc.'s Gross Profit growth was (9.8%), which is lower than industry growth of (0.1%). It indicates that West Pharmaceutical Services, Inc.'s Gross Profit growth is Bad.